These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28789853)

  • 1. Targeted human papillomavirus vaccination for young men who have sex with men in Australia yields significant population benefits and is cost-effective.
    Zhang L; Regan DG; Ong JJ; Gambhir M; Chow EPF; Zou H; Law M; Hocking J; Fairley CK
    Vaccine; 2017 Sep; 35(37):4923-4929. PubMed ID: 28789853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis.
    Kim JJ
    Lancet Infect Dis; 2010 Dec; 10(12):845-52. PubMed ID: 21051295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of human papillomavirus vaccination strategies among men who have sex with men in China: a modeling study.
    Li Y; Lin YF; Wu X; Zhou X; Tian T; Guo Z; Fu L; Yang L; Lu Z; Fan S; Lu Y; Ke W; Zou H
    Front Immunol; 2023; 14():1197191. PubMed ID: 37426648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach.
    Bogaards JA; Mooij SH; Xiridou M; Schim van der Loeff MF
    PLoS Med; 2019 Mar; 16(3):e1002756. PubMed ID: 30830901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should human papillomavirus vaccination target women over age 26, heterosexual men and men who have sex with men? A targeted literature review of cost-effectiveness.
    Soe NN; Ong JJ; Ma X; Fairley CK; Latt PM; Jing J; Cheng F; Zhang L
    Hum Vaccin Immunother; 2018; 14(12):3010-3018. PubMed ID: 30024823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With Men.
    Lin A; Ong KJ; Hobbelen P; King E; Mesher D; Edmunds WJ; Sonnenberg P; Gilson R; Bains I; Choi YH; Tanton C; Soldan K; Jit M
    Clin Infect Dis; 2017 Mar; 64(5):580-588. PubMed ID: 28011615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of HPV and attitudes towards HPV vaccination amongst men who have sex with men: A qualitative analysis.
    Nadarzynski T; Smith H; Richardson D; Pollard A; Llewellyn C
    Br J Health Psychol; 2017 May; 22(2):345-361. PubMed ID: 28191723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study.
    Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Garland SM; Cornall AM; Atchison S; Hocking JS; Bradshaw CS; Balgovind P; Murray GL; Chen MY
    Lancet Infect Dis; 2021 Oct; 21(10):1448-1457. PubMed ID: 34043963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How very young men who have sex with men view vaccination against human papillomavirus.
    Zou H; Grulich AE; Cornall AM; Tabrizi SN; Garland SM; Prestage G; Bradshaw CS; Hocking JS; Morrow A; Fairley CK; Chen MY
    Vaccine; 2014 Jun; 32(31):3936-41. PubMed ID: 24852719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands.
    Simons JJM; Vida N; Westra TA; Postma MJ
    Vaccine; 2020 Jun; 38(30):4687-4694. PubMed ID: 32451211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand.
    Blakely T; Kvizhinadze G; Karvonen T; Pearson AL; Smith M; Wilson N
    Vaccine; 2014 May; 32(22):2645-56. PubMed ID: 24662710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.
    Bogaards JA; Wallinga J; Brakenhoff RH; Meijer CJ; Berkhof J
    BMJ; 2015 May; 350():h2016. PubMed ID: 25985328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study.
    Zou H; Tabrizi SN; Grulich AE; Hocking JS; Bradshaw CS; Cornall AM; Morrow A; Prestage G; Law MG; Garland SM; Chen MY; Fairley CK
    Lancet Infect Dis; 2015 Jan; 15(1):65-73. PubMed ID: 25435055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys.
    Burger EA; Sy S; Nygård M; Kristiansen IS; Kim JJ
    PLoS One; 2014; 9(3):e89974. PubMed ID: 24651645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of male human papillomavirus vaccination in preventing cervical cancer and genital warts in a low-resource setting.
    Sharma M; Sy S; Kim JJ
    BJOG; 2016 May; 123(6):917-26. PubMed ID: 26176301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HPV vaccination in boys and men : update and recommendations].
    Rossi C; Vanhomwegen C; Laurent F
    Rev Med Brux; 2018; 39(4):352-358. PubMed ID: 30321000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States.
    Laprise JF; Chesson HW; Markowitz LE; Drolet M; Martin D; Bénard É; Brisson M
    Ann Intern Med; 2020 Jan; 172(1):22-29. PubMed ID: 31816629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study.
    Laprise JF; Drolet M; Boily MC; Jit M; Sauvageau C; Franco EL; Lemieux-Mellouki P; Malagón T; Brisson M
    Vaccine; 2014 Oct; 32(44):5845-53. PubMed ID: 25131743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.
    Demarteau N; Van Kriekinge G; Simon P
    Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France.
    Majed L; Bresse X; El Mouaddin N; Schmidt A; Daniels VJ; Pavelyev A; Levy-Bachelot L; Elbasha E
    Vaccine; 2021 Jan; 39(2):438-446. PubMed ID: 33261895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.